These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 27130232

  • 1. The Effect of Levonorgestrel on Fibrinolytic Factors in Human Endometrial Endothelial Cells.
    Pakrashi T, Taylor JE, Nelson A, Archer DF, Jacot T.
    Reprod Sci; 2016 Nov; 23(11):1536-1541. PubMed ID: 27130232
    [Abstract] [Full Text] [Related]

  • 2. Drospirenone Effects on the Plasminogen Activator System in Immortalized Human Endometrial Endothelial Cells.
    Sabouni R, Archer DF, Jacot T.
    Reprod Sci; 2021 Jul; 28(7):1974-1980. PubMed ID: 33559058
    [Abstract] [Full Text] [Related]

  • 3. Effects of thrombin on steroid-modulated cultured endometrial stromal cell fibrinolytic potential.
    Lockwood CJ, Krikun G, Aigner S, Schatz F.
    J Clin Endocrinol Metab; 1996 Jan; 81(1):107-12. PubMed ID: 8550736
    [Abstract] [Full Text] [Related]

  • 4. The effect of levonorgestrel-releasing intrauterine system use on menstrual blood loss and the hemostatic, fibrinolytic/inhibitor systems in women with menorrhagia.
    Koh SC, Singh K.
    J Thromb Haemost; 2007 Jan; 5(1):133-8. PubMed ID: 17010149
    [Abstract] [Full Text] [Related]

  • 5. Biological mechanisms underlying the clinical effects of RU 486: modulation of cultured endometrial stromal cell plasminogen activator and plasminogen activator inhibitor expression.
    Lockwood CJ, Krikun G, Papp C, Aigner S, Schatz F.
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1100-5. PubMed ID: 7714076
    [Abstract] [Full Text] [Related]

  • 6. [Plasminogen activators and plasminogen activator inhibitor type-1 in human endometrium].
    Chen GA, Feng Q, Zhang LZ, Liu YX.
    Sheng Li Xue Bao; 1992 Oct; 44(5):502-9. PubMed ID: 1293766
    [Abstract] [Full Text] [Related]

  • 7. Induction of endometrial plasminogen activator-inhibitor 1: a possible mechanism contributing to the effect of intrauterine levonorgestrel in the treatment of menorrhagia.
    Rutanen E, Hurskainen R, Finne P, Nokelainen K.
    Fertil Steril; 2000 May; 73(5):1020-4. PubMed ID: 10785231
    [Abstract] [Full Text] [Related]

  • 8. Prostaglandin E2 regulates the plasminogen activator pathway in human endometrial endothelial cells: a new in vitro model to investigate heavy menstrual bleeding.
    Sadek S, Jacot TA, Duffy DM, Archer DF.
    F S Sci; 2024 Jul 20. PubMed ID: 39038609
    [Abstract] [Full Text] [Related]

  • 9. Plasminogen activator activity during decidualization of human endometrial stromal cells is regulated by plasminogen activator inhibitor 1.
    Schatz F, Aigner S, Papp C, Toth-Pal E, Hausknecht V, Lockwood CJ.
    J Clin Endocrinol Metab; 1995 Aug 20; 80(8):2504-10. PubMed ID: 7629251
    [Abstract] [Full Text] [Related]

  • 10. Effects of hormones on uPA, PAI-1 and suPAR from cultured endometrial and ovarian endometriotic stromal cells.
    Guan YM, Carlberg M, Bruse C, Carlström K, Bergqvist A.
    Acta Obstet Gynecol Scand; 2002 May 20; 81(5):389-97. PubMed ID: 12027810
    [Abstract] [Full Text] [Related]

  • 11. Expression of vascular endothelial growth factors and their receptors in human endometrium from women experiencing abnormal bleeding patterns after prolonged use of a levonorgestrel-releasing intrauterine system.
    Möller B, Rönnerdag M, Wang G, Odlind V, Olovsson M.
    Hum Reprod; 2005 May 20; 20(5):1410-7. PubMed ID: 15760960
    [Abstract] [Full Text] [Related]

  • 12. Urokinase plasminogen activator, uPa receptor, and its inhibitor in vernal keratoconjunctivitis.
    Leonardi A, Brun P, Sartori MT, Cortivo R, Dedominicis C, Saggiorato G, Abatangelo G, Secchi AG.
    Invest Ophthalmol Vis Sci; 2005 Apr 20; 46(4):1364-70. PubMed ID: 15790903
    [Abstract] [Full Text] [Related]

  • 13. Biological mechanisms underlying the clinical effects of mifepristone (RU 486) on the endometrium.
    Papp C, Schatz F, Krikun G, Hausknecht V, Lockwood CJ.
    Early Pregnancy (Cherry Hill); 2000 Oct 20; 4(4):230-9. PubMed ID: 11742418
    [Abstract] [Full Text] [Related]

  • 14. The effect of intrauterine levonorgestrel use on the expression of c-JUN, oestrogen receptors, progesterone receptors and Ki-67 in human endometrium.
    Salmi A, Pakarinen P, Peltola AM, Rutanen EM.
    Mol Hum Reprod; 1998 Dec 20; 4(12):1110-5. PubMed ID: 9872360
    [Abstract] [Full Text] [Related]

  • 15. Measurement of plasminogen activator system components in plasma and tumor tissue extracts obtained from patients with breast cancer: an EORTC Receptor and Biomarker Group collaboration.
    Grebenchtchikov N, Maguire TM, Riisbro R, Geurts-Moespot A, O'Donovan N, Schmitt M, McGreal G, McDermott E, O'Higgins N, Brünner N, Sweep CG, Duffy MJ.
    Oncol Rep; 2005 Jul 20; 14(1):235-9. PubMed ID: 15944795
    [Abstract] [Full Text] [Related]

  • 16. Endometrial morphology during hormone replacement therapy with estradiol gel combined to levonorgestrel-releasing intrauterine device or natural progesterone.
    Suvanto-Luukkonen E, Malinen H, Sundström H, Penttinen J, Kauppila A.
    Acta Obstet Gynecol Scand; 1998 Aug 20; 77(7):758-63. PubMed ID: 9740525
    [Abstract] [Full Text] [Related]

  • 17. Progesterone regulation of plasminogen activator inhibitor 1 (PAI-1) antigen and mRNA levels in human endometrial stromal cells.
    Casslén B, Urano S, Ny T.
    Thromb Res; 1992 Apr 01; 66(1):75-87. PubMed ID: 1384159
    [Abstract] [Full Text] [Related]

  • 18. Prostaglandin E2 regulates production of plasminogen activator isoenzymes, urokinase receptor, and plasminogen activator inhibitor-1 in primary cultures of rat calvarial osteoblasts.
    Allan EH, Martin TJ.
    J Cell Physiol; 1995 Dec 01; 165(3):521-9. PubMed ID: 7593231
    [Abstract] [Full Text] [Related]

  • 19. Basal release of urokinase plasminogen activator, plasminogen activator inhibitor-1, and soluble plasminogen activator receptor from separated and cultured endometriotic and endometrial stromal and epithelial cells.
    Bruse C, Guan Y, Carlberg M, Carlström K, Bergqvist A.
    Fertil Steril; 2005 Apr 01; 83 Suppl 1():1155-60. PubMed ID: 15831288
    [Abstract] [Full Text] [Related]

  • 20. Levonorgestrel-intrauterine system effects on hemostasis and menstrual blood loss in women seeking contraception.
    Koh SC, Singh K.
    J Obstet Gynaecol Res; 2010 Aug 01; 36(4):838-44. PubMed ID: 20666954
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.